Surgery Partners (1SP) Price & Analysis

1 Followers

1SP Stock Chart & Stats

€11.90

€0.60(4.55%)

At close: Jul 24 4:00 PM EDT

€11.90

€0.60(4.55%)

Day’s Range― - ―

52-Week Range€9.80 - €19.80

Previous CloseN/A

Volume360.00

Average Volume (3M)0.00

Market Cap

€1.63B

Enterprise Value€7.80K

Total Cash (Recent Filing)€216.70M

Total Debt (Recent Filing)€4.02B

Price to Earnings (P/E)―

Beta0.90

Next Earnings

Nov 10, 2026

EPS Estimate

0.1

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.69

Shares Outstanding130,918,260

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio0.47

Price to Book (P/B)1.15

Price to Sales (P/S)0.59

P/FCF Ratio10.05

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

€15.78

Price Target Upside32.62% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering8

EPS Forecast (FY)0.39

Revenue Forecast (FY)€2.95B

Bulls Say, Bears Say

Bulls Say

Same-facility Revenue GrowthPositive same-facility growth indicates sustained demand and pricing power across the existing network, reducing reliance on acquisitions for expansion. Continued case growth and higher revenue per case can support operating leverage and strengthen the company’s core outpatient platform over the next several quarters.

Physician Recruitment Supports GrowthPhysician recruitment is strategically important because partners help direct procedures to Surgery Partners facilities and expand specialty capacity. The larger recruiting cohort and stronger initial revenue contribution suggest improving access to volume, supporting durable facility utilization and future organic growth.

Portfolio Optimization And DeleveragingThe planned divestiture could materially improve financial flexibility by converting a capital-intensive asset into cash and reducing leverage. A simpler focus on the core short-stay surgical profile may also improve management focus, cash conversion, and the consistency of future capital allocation.

Bears Say

Elevated Leverage Constrains FlexibilityHigh leverage leaves Surgery Partners more exposed to operating volatility and refinancing conditions, while limiting capacity to invest aggressively in facilities, acquisitions, or other growth initiatives. Debt reduction therefore remains important for improving resilience and allowing more flexible capital allocation.

Persistent Net LossesOngoing net losses show that stronger revenue and operating profitability have not yet translated into sustainable earnings for shareholders. Continued below-the-line costs, including financing burdens, can limit internally funded growth and make the business less resilient during periods of slower volume or reimbursement pressure.

Adjusted EBITDA And Margin PressureDeclining adjusted EBITDA and margins indicate that recent revenue growth is not fully converting into incremental operating profit. Higher expense ratios versus the prior year and weaker profitability can constrain cash available for debt reduction, while making achievement of guidance more dependent on operational improvement.

Surgery Partners News

Surgery Partners price target raised to $15 from $14 at JPMorgan

JPMorgan analyst Benjamin Rossi raised the firm’s price target on Surgery Partners (SGRY) to $15 from $14 and...

2d ago

SGRY

Short Report: Charter Communications short interest at record high

Welcome to this week’s installment of “The Short Interest Report” – The Fly’s weekly recap of short interest...

24d ago

WIX

CHTR

Surgery Partners Earnings Call Highlights Strategic Reset

Surgery Partners Inc. (($SGRY)) has held its Q2 earnings call. Read on for the main highlights of the...

28d ago

SGRY

Surgery Partners price target raised to $19 from $17 at TD Cowen

TD Cowen raised the firm’s price target on Surgery Partners (SGRY) to $19 from $17 and keeps a...

1M ago

SGRY

Surgery Partners’ improved cash conversion not priced in, says Cantor Fitzgerald

Surgery Partners (SGRY)’ Idaho Falls divestiture should improve cash conversion, reduce leverage, and accelerate ex-Idaho Falls organic growth,...

1M ago

SGRY

Surgery Partners price target lowered to $19 from $20 at RBC Capital

RBC Capital lowered the firm’s price target on Surgery Partners (SGRY) to $19 from $20 and keeps an...

1M ago

SGRY

Midday Fly By: Intel announces $15B offering, Meta unveils Muse Glimmer

The major averages were mixed near noon to start the week, as traders are beginning to doubt that...

1M ago

ACH

Surgery Partners Reports Modest Q2 Revenue Growth, Net Loss

Surgery Partners ( ($SGRY) ) has issued an update. On August 10, 2026, Surgery Partners reported that second-quarter...

1M ago

SGRY

Surgery Partners reports Q2 adjusted EPS 10c, consensus 7c

Reports Q2 revenue $848.9M, consensus $830.32M. Same-facility revenues increased 5% for the second quarter. Eric Evans, Chief Executive...

1M ago

SGRY

Surgery Partners backs FY26 revenue view $3.35B-$3.45B, consensus $3.41B

The company said, “The Company reaffirmed its outlook for 2026 revenues to be in the range of $3.35...

1M ago

SGRY

SGRY Earnings this Week: How Will it Perform?

Surgery Partners Inc. (SGRY) is scheduled to report 2nd quarter earnings on 08/10/2026, before the market opens. Regarding...

1M ago

SGRY

Surgery Partners Announces Idaho Falls Hospital Divestiture Agreement

Surgery Partners ( ($SGRY) ) just unveiled an announcement. On July 21, 2026, Surgery Partners and Intermountain Health...

2M ago

SGRY

Surgery Partners to sell Mountain View, Idaho Falls hospitals interest for $1.5B

Surgery Partners (SGRY) announced it, along with its existing partner Intermountain Health, has placed into escrow signature pages...

2M ago

SGRY

Surgery Partners Shareholders Reaffirm Board, Pay and Auditor

Surgery Partners ( ($SGRY) ) has issued an update. On June 5, 2026, Surgery Partners held its Annual...

3M ago

SGRY

1SP FAQ

What was Surgery Partners Inc’s price range in the past 12 months?

Surgery Partners Inc lowest stock price was €9.80 and its highest was €19.80 in the past 12 months.

What is Surgery Partners Inc’s market cap?

Surgery Partners Inc’s market cap is €1.63B.

When is Surgery Partners Inc’s upcoming earnings report date?

Surgery Partners Inc’s upcoming earnings report date is Nov 10, 2026 which is in 55 days.

How were Surgery Partners Inc’s earnings last quarter?

Surgery Partners Inc released its earnings results on Aug 10, 2026. The company reported €0.086 earnings per share for the quarter, beating the consensus estimate of €0.05 by €0.036.

Is Surgery Partners Inc overvalued?

According to Wall Street analysts Surgery Partners Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Surgery Partners Inc pay dividends?

Surgery Partners Inc does not currently pay dividends.

What is Surgery Partners Inc’s EPS estimate?

Surgery Partners Inc’s EPS estimate is 0.1.

How many shares outstanding does Surgery Partners Inc have?

Surgery Partners Inc has 130,918,260 shares outstanding.

What happened to Surgery Partners Inc’s price movement after its last earnings report?

Surgery Partners Inc reported an EPS of €0.086 in its last earnings report, beating expectations of €0.05. Following the earnings report the stock price went up 2.256%.

Which hedge fund is a major shareholder of Surgery Partners Inc?

Currently, no hedge funds are holding shares in DE:1SP

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Surgery Partners Stock Smart Score

Underperform

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

1.19%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

Surgery Partners Inc

Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilities—specifically, 108 ambulatory surgical centers and 18 surgical hospitals—situated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.

Surgery Partners (1SP) Earnings & Revenues

Historic Earnings Reports

1SP Company Deck

1SP Earnings Call

Q2 2026

0:00 / 0:00

Earnings Call Sentiment|Positive

The call emphasized healthy organic performance (revenue growth, strong same-facility metrics, physician recruiting, case acuity expansion, sequential expense improvements) and a strategic portfolio optimization (Idaho Falls sale) expected to simplify the business, improve cash conversion and reduce leverage. Headwinds include a modest decline in adjusted EBITDA and margins year-to-date, higher interest expense, a ~350 bps decline in commercial mix, elevated leverage metrics, and muted M&A activity in 2026. On balance, the positives (organic growth, operational improvements, substantial deleveraging transaction and reaffirmed guidance) outweigh the negatives.View all DE:1SP earnings summaries

1SP Stock 12 Month Forecast

Average Price Target

€15.78

▲(32.62% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"9":"€9","12":"€12","15":"€15","18":"€18","21":"€21"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":20.71344,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€20.71</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.78166857142857,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€15.78</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12.08284,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€12.08</span>\n  </div></div>","useHTML":true}}],"tickPositions":[9,12,15,18,21],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.3,12.947187692307693,13.594375384615384,14.241563076923077,14.88875076923077,15.53593846153846,16.183126153846153,16.830313846153846,17.47750153846154,18.124689230769228,18.771876923076924,19.419064615384613,20.066252307692306,{"y":20.71344,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.3,12.56782065934066,12.835641318681319,13.10346197802198,13.371282637362638,13.639103296703297,13.906923956043956,14.174744615384615,14.442565274725274,14.710385934065933,14.978206593406593,15.246027252747252,15.513847912087911,{"y":15.78166857142857,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.3,12.283295384615386,12.26659076923077,12.249886153846154,12.233181538461539,12.216476923076923,12.199772307692308,12.183067692307691,12.166363076923076,12.149658461538461,12.132953846153846,12.11624923076923,12.099544615384614,{"y":12.08284,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":19.2,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.9,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.7,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.5,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.3,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.4,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.4,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.4,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.8,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.3,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.5,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.2,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.3,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >